These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1574599)

  • 21. Outcomes of adjuvant radiation therapy for breast cancer in women with ataxia-telangiectasia mutations.
    Su Y; Swift M
    JAMA; 2001 Nov; 286(18):2233-4. PubMed ID: 11710885
    [No Abstract]   [Full Text] [Related]  

  • 22. Cytogenetic studies in ataxia telangiectasia & their use in prenatal diagnosis.
    Chowdhury MR; Singh G; Shukla A; Verma IC
    Indian J Med Res; 1996 Mar; 103():155-8. PubMed ID: 9062042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of the ataxia-telangiectasia gene (ATM) in breast cancer. A-T heterozygotes seem to have an increased risk but its size is unknown.
    Lavin M
    BMJ; 1998 Aug; 317(7157):486-7. PubMed ID: 9712591
    [No Abstract]   [Full Text] [Related]  

  • 24. Genetic predisposition in breast cancer.
    Scott D; Spreadborough A; Levine E; Roberts SA
    Lancet; 1994 Nov; 344(8934):1444. PubMed ID: 7968110
    [No Abstract]   [Full Text] [Related]  

  • 25. Restoration of radiation resistance in ataxia telangiectasia cells by the introduction of normal human chromosome 11.
    Komatsu K; Kodama S; Okumura Y; Koi M; Oshimura M
    Mutat Res; 1990 Mar; 235(2):59-63. PubMed ID: 2155385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correspondence re: A. Rothfuss et al., Induced micronucleus frequencies in peripheral blood lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families. Cancer Res., 60: 390-394, 2000.
    Baria K; Warren C; Roberts SA; West CM; Evans DG; Varley JM; Scott D
    Cancer Res; 2001 Aug; 61(15):5948-9. PubMed ID: 11479238
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of ataxia-telangiectasia heterozygotes in familial breast cancer.
    Chen J; Birkholtz GG; Lindblom P; Rubio C; Lindblom A
    Cancer Res; 1998 Apr; 58(7):1376-9. PubMed ID: 9537233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ataxia-telangiectasia: an interdisciplinary approach to pathogenesis.
    Gatti RA; Boder E; Vinters HV; Sparkes RS; Norman A; Lange K
    Medicine (Baltimore); 1991 Mar; 70(2):99-117. PubMed ID: 2005780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Public health burden of cancer in ataxia-telangiectasia heterozygotes.
    Swift M
    J Natl Cancer Inst; 2001 Jan; 93(2):84-5. PubMed ID: 11208872
    [No Abstract]   [Full Text] [Related]  

  • 30. The pathogenesis of ataxia-telangiectasia. Learning from a Rosetta Stone.
    Gatti RA; Becker-Catania S; Chun HH; Sun X; Mitui M; Lai CH; Khanlou N; Babaei M; Cheng R; Clark C; Huo Y; Udar NC; Iyer RK
    Clin Rev Allergy Immunol; 2001 Feb; 20(1):87-108. PubMed ID: 11269230
    [No Abstract]   [Full Text] [Related]  

  • 31. Risk of breast cancer and other cancers in heterozygotes for ataxia-telangiectasia.
    Inskip HM; Kinlen LJ; Taylor AM; Woods CG; Arlett CF
    Br J Cancer; 1999 Mar; 79(7-8):1304-7. PubMed ID: 10098776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families.
    Janin N; Andrieu N; Ossian K; Laugé A; Croquette MF; Griscelli C; Debré M; Bressac-de-Paillerets B; Aurias A; Stoppa-Lyonnet D
    Br J Cancer; 1999 Jun; 80(7):1042-5. PubMed ID: 10362113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterogeneity in ataxia-telangiectasia: classical phenotype associated with intermediate cellular radiosensitivity.
    Chessa L; Petrinelli P; Antonelli A; Fiorilli M; Elli R; Marcucci L; Federico A; Gandini E
    Am J Med Genet; 1992 Mar; 42(5):741-6. PubMed ID: 1632451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health risks for ataxia-telangiectasia mutated heterozygotes: a systematic review, meta-analysis and evidence-based guideline.
    van Os NJ; Roeleveld N; Weemaes CM; Jongmans MC; Janssens GO; Taylor AM; Hoogerbrugge N; Willemsen MA
    Clin Genet; 2016 Aug; 90(2):105-17. PubMed ID: 26662178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a potentially radiosensitive subgroup among patients with breast cancer.
    Lavin MF; Bennett I; Ramsay J; Gardiner RA; Seymour GJ; Farrell A; Walsh M
    J Natl Cancer Inst; 1994 Nov; 86(21):1627-34. PubMed ID: 7932827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Re: Gutiérrez-Enriquez S, Fernet M, Dörk T, Bremer M, Lauge A, Stoppa-Lyonnet D, Moullan N, Angèle S, Hall J, "Functional consequences of the ATM sequence variants for chromosomal radiosensitivity".
    Swift M
    Genes Chromosomes Cancer; 2005 Feb; 42(2):200-1; author reply 202-3. PubMed ID: 15543621
    [No Abstract]   [Full Text] [Related]  

  • 37. [Ataxia telangiectasia: what impact in clinical oncology?].
    Stoppa-Lyonnet D; Aurias A
    Bull Cancer; 1992; 79(7):645-50. PubMed ID: 1467590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiosensitivity and the clinician.
    Lancet; 1985 Jul; 2(8445):23-5. PubMed ID: 2861460
    [No Abstract]   [Full Text] [Related]  

  • 39. Cancer risks in A-T heterozygotes.
    Easton DF
    Int J Radiat Biol; 1994 Dec; 66(6 Suppl):S177-82. PubMed ID: 7836845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of breast cancer in ataxia-telangiectasia.
    Hall EJ; Geard CR; Brenner DJ
    N Engl J Med; 1992 May; 326(20):1358-9; author reply 1360-1. PubMed ID: 1565153
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.